Agilon Health, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-248.00
-194.00
-90.00
-404.00
-62.00
-114.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
130.00
-10.00
-59.00
-55.00
6.00
33.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-57.00
-156.00
-130.00
-148.00
-53.00
-103.00
Cash Flow from Investing Activities
139.00
-44.00
-444.00
-90.00
22.00
-5.00
Cash Flow from Financing Activities
-2.00
-193.00
28.00
1,154.00
24.00
176.00
Net Cash Inflow / Outflow
79.00
-393.00
-547.00
915.00
-6.00
67.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Agilon Health, Inc.
Figures in Million
consolidated Cash Flow Results
Change(USD)
Change(%)
Profit Before Tax
-248.826
1530.393
-1,778.00
-116.26%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
130.589
-29.821
159.00
537.91%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-57.777
2028.718
-2,085.00
-102.85%
Cash Flow from Investing Activities
139.891
-816.708
955.00
117.13%
Cash Flow from Financing Activities
-2.583
-778.338
776.00
99.67%
Net Cash Inflow / Outflow
79.531
415.191
-336.00
-80.84%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
-18.481
18.00
100.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 63.01% vs -19.41% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-57.78
-156.20
63.01%






